. Author manuscript; available in PMC: 2012 Jul 1.

Published in final edited form as: Int J Radiat Oncol Biol Phys. 2011 Apr 12;80(3):645–654. doi: 10.1016/j.ijrobp.2010.12.071

Table 2.

The role of GKRS in treatment of melanoma brain metastases.

Study	Number of patients	1 year LC	1 year OS	Comments

Yu C³⁸	122	90%	7 months	Improved survival on MV analysis = total intracranial tumor volume <3 cm³ inactive systemic disease

Radbill³⁹	51	81%	26 weeks

	GKRS alone = 32